SCHEMBL7673879

SCHEMBL7673879

CC(C)(C)OC(=O)NCCN1CCc2ccc(Cl)cc21

nearest known ligand 0.53

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 10/20 0.53
HTR2A P28223 1/20 0.48
HTR2C P28335 1/20 0.48
HTR2B P41595 1/20 0.48
CYP11B1 P15538 1/20 0.45
CYP11B2 P19099 1/20 0.45
NOTUM Q6P988 1/20 0.45
IDO1 P14902 2/20 0.44
TP53 P04637 1/20 0.41
MAPT P10636 1/20 0.41
CTSL P07711 1/20 0.41
CTSS P25774 1/20 0.41
CTSK P43235 1/20 0.41
HDAC1 Q13547 1/20 0.41
HDAC6 Q9UBN7 1/20 0.41
FNTA P49354 1/20 0.41
FNTB P49356 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8078377 0.87 DRD2 (0.46) DRD2CYP11B1CYP11B2CTSLCTSS
SCHEMBL7677565 0.86 CYP1A2 (0.48) DRD2HTR2AHTR2CHTR2BCYP11B1
SCHEMBL7674588 0.81 HTR2A (0.56) DRD2HTR2AHTR2CHTR2BNOTUM
SCHEMBL7674593 0.81 HTR2A (0.56) DRD2HTR2AHTR2CHTR2BNOTUM
SCHEMBL5212016 0.80 DRD2 (0.47) DRD2CYP11B1CYP11B2
SCHEMBL31129885 0.79 CYP11B1 (0.47) DRD2CYP11B1CYP11B2
SCHEMBL5212333 0.77 DRD2 (0.49) DRD2MAPT
SCHEMBL18688203 0.77 DRD2 (0.56) DRD2CYP11B1CYP11B2HDAC1HDAC6
SCHEMBL21281416 0.74 MTNR1A (0.46) DRD2CYP11B1CYP11B2
SCHEMBL15690446 0.74 DRD2 (0.48) DRD2CYP11B1CYP11B2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6380238-B1 FOR THERAPY OF DISORDERS OF THE CENTRAL NERVOUS SYSTEM; DAMAGE TO THE CENTRAL NERVOUS SYSTEM; CARDIOVASCULAR DISORDERS; GASTROINTESTINAL DISORDERS; DIABETES INSIPIDUS, AND SLEEP APNEA VERNALIS RESEARCH LIMITED (GB) 2002-04-30 US disclosed
EP-1109784-A1 INDOLINE DERIVATIVES AS 5-HT2B AND/OR 5-HT2C RECEPTOR LIGANDS VERNALIS RESEARCH LIMITED (GB) 2001-06-27 EP disclosed
WO-2000012475-A1 INDOLINE DERIVATIVES AS 5-HT2B AND/OR 5-HT2C RECEPTOR LIGANDS VERNALIS RESEARCH LIMITED (GB) 2000-03-09 WO disclosed